Your browser doesn't support javascript.
loading
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors.
Cheng, Hui; Ang, Heather Yin-Kuan; A El Farran, Chadi; Li, Pin; Fang, Hai Tong; Liu, Tong Ming; Kong, Say Li; Chin, Michael Lingzi; Ling, Wei Yin; Lim, Edwin Kok Hao; Li, Hu; Huber, Tara; Loh, Kyle M; Loh, Yuin-Han; Lim, Bing.
Afiliação
  • Cheng H; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Ang HY; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • A El Farran C; Epigenetics and Cell Fates Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore.
  • Li P; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543, Singapore.
  • Fang HT; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Liu TM; Epigenetics and Cell Fates Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore.
  • Kong SL; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Chin ML; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Ling WY; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Lim EK; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Li H; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Huber T; Department of Molecular Pharmacology &Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Loh KM; Stem Cell and Regenerative Biology Group, Genome Institute of Singapore, Singapore 138672, Singapore.
  • Loh YH; Department of Developmental Biology, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
  • Lim B; Epigenetics and Cell Fates Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore.
Nat Commun ; 7: 13396, 2016 11 21.
Article em En | MEDLINE | ID: mdl-27869129
ABSTRACT
Recent efforts have attempted to convert non-blood cells into hematopoietic stem cells (HSCs) with the goal of generating blood lineages de novo. Here we show that hematopoietic transcription factors Scl, Lmo2, Runx1 and Bmi1 can convert a developmentally distant lineage (fibroblasts) into 'induced hematopoietic progenitors' (iHPs). Functionally, iHPs generate acetylcholinesterase+ megakaryocytes and phagocytic myeloid cells in vitro and can also engraft immunodeficient mice, generating myeloerythoid and B-lymphoid cells for up to 4 months in vivo. Molecularly, iHPs transcriptionally resemble native Kit+ hematopoietic progenitors. Mechanistically, reprogramming factor Lmo2 implements a hematopoietic programme in fibroblasts by rapidly binding to and upregulating the Hhex and Gfi1 genes within days. Moreover the reprogramming transcription factors also require extracellular BMP and MEK signalling to cooperatively effectuate reprogramming. Thus, the transcription factors that orchestrate embryonic hematopoiesis can artificially reconstitute this programme in developmentally distant fibroblasts, converting them into engraftable blood progenitors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Células-Tronco Hematopoéticas / Reprogramação Celular / Fibroblastos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Células-Tronco Hematopoéticas / Reprogramação Celular / Fibroblastos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article